Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse
Clinical trial NCT03779230 · COMPLETED
Trial details
- NCT number
- NCT03779230
- Sponsor
- Philogen S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2023-06-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.